Manufacturers Life Insurance Company, The Clearside Biomedical, Inc. Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.0 - $6.12 $12,057 - $73,788	-12,057 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$6.03 - $11.24 $63,532 - $118,424	-10,536 Reduced 46.63%	12,057 $74,000
Q2 2018 Aug 14, 2018	BUY	$8.91 - $14.54 $49,495 - $80,769	5,555 Added 32.6%	22,593 $241,000
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $68,549 - $175,743	12,307 Added 260.14%	17,038 $183,000
Q4 2017 Feb 08, 2018	SELL	$5.78 - $9.12 $78,319 - $123,575	-13,550 Reduced 74.12%	4,731 $33,000
Q3 2017 Nov 14, 2017	BUY	$6.73 - $8.74 $123,031 - $159,775	18,281	18,281 $159,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $52.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.